• <em>APOC3</em> Interference for Familial Chylomicronaemia Syndrome
• A Comprehensive Update on the Chylomicronemia Syndrome
• A lipoprotein lipase-GPI-anchored high-density lipoprotein-binding protein 1 fusion lowers triglycerides in mice: Implications for managing familial chylomicronemia syndrome
• A novel mutation in GPIHBP1 causes familial chylomicronemia syndrome
• Acute pancreatitis risk in multifactorial chylomicronemia syndrome depends on the molecular cause of severe hypertriglyceridemia
• Analyses of familial chylomicronemia syndrome in Pereira, Colombia 2010-2020: a cross-sectional study
• Apolipoprotein C-III, familial chylomicronemia syndrome, and olezarsen
• Biochemical, Clinical, and Genetic Characteristics of Mexican Patients with Primary Hypertriglyceridemia, Including the First Case of Hyperchylomicronemia Syndrome Due to GPIHBP1 Deficiency
• Brazilian Position Statement for Familial Chylomicronemia Syndrome - 2023
• Case Report: Next-Generation Sequencing Identified a Novel Pair of Compound-Heterozygous Mutations of <em>LPL</em> Gene Causing Lipoprotein Lipase Deficiency
• Challenges in familial chylomicronemia syndrome diagnosis and management across Latin American countries: An expert panel discussion
• Characterizing familial chylomicronemia syndrome: Baseline data of the APPROACH study
• Cholesterol efflux capacity is increased in subjects with familial hypercholesterolemia in a retrospective case-control study
• Chylomicronemia: Differences between familial chylomicronemia syndrome and multifactorial chylomicronemia
• Clinical and biochemical features of different molecular etiologies of familial chylomicronemia
• Clinical characteristics of adult and paediatric patients with familial hypercholesterolemia: A real-life cross-sectional study from the Turkish National Database
• Clinical profile, genetic spectrum and therapy evaluation of 19 Chinese pediatric patients with lipoprotein lipase deficiency
• Comprehensive (apo)lipoprotein profiling in patients with genetic hypertriglyceridemia using LC-MS and NMR spectroscopy
• Correlation between chylomicronemia diagnosis scores and post-heparin lipoprotein lipase activity
• Dietary intervention for children and adolescents with familial hypercholesterolaemia
• Disappearance of recurrent pancreatitis after splenectomy in familial chylomicronemia syndrome
• Efficacy and safety of lomitapide in familial chylomicronaemia syndrome
• Efficacy of therapeutic plasma exchange in reducing the incidence of recurrent pancreatitis related to familial chylomicronemia
• Estimating health state utilities associated with a rare disease: familial chylomicronemia syndrome (FCS)
• Etiology and emerging treatments for familial chylomicronemia syndrome
• Evaluation of efficacy and safety of antisense inhibition of apolipoprotein C-III with volanesorsen in patients with severe hypertriglyceridemia
• Exchange Transfusion: A Good Option for the Acute Treatment of Familial Chylomicronemia Syndrome in the Neonatal Period
• Familial Chylomicronemia Syndrome (FCS): Recent Data on Diagnosis and Treatment
• Familial chylomicronemia syndrome caused by compound heterozygous mutation of lipoprotein lipase gene: A case report and review of literature
• Familial chylomicronemia syndrome due to a heterozygous deletion of the chromosome 8 treated with the apoCIII inhibitor volanesorsen: A case report
• Familial Chylomicronemia Syndrome With a Novel Homozygous LPL Mutation Identified in Three Siblings in Their 50s
• Familial Chylomicronemia Syndrome-Induced Acute Necrotizing Pancreatitis during Pregnancy
• Familial chylomicronemia syndrome: A rare but devastating autosomal recessive disorder characterized by refractory hypertriglyceridemia and recurrent pancreatitis
• Familial chylomicronemia syndrome: Bringing to life dietary recommendations throughout the life span
• Familial chylomicronemia syndrome: case reports of siblings with deletions of the GPIHBP1 gene
• Familial Chylomicronemia Syndrome: Clinical Characteristics and Long-Term Cardiovascular Outcomes
• Familial chylomicronemia syndrome: pediatric experience in Argentina
• Familial chylomicronemia syndrome: The first case reported in Ecuador
• Familial chylomicronemia syndrome. A sixty year follow-up in two siblings and their kindreds. Nosological and clinical considerations
• Familial Hyperchylomicronemia Syndrome
• Familial Hyperchylomicronemia Syndrome
• Filling the gap: Genetic risk assessment in hypercholesterolemia using LDL-C and LPA genetic scores
• Frameshift coding sequence variants in the LPL gene: identification of two novel events and exploration of the genotype-phenotype relationship for variants reported to date
• Genetics of Hypertriglyceridemia
• GRP78/BiP alleviates oxLDL-induced hepatotoxicity in familial hypercholesterolemia caused by missense variants of LDLR in a HepG2 cellular model
• Hypertriglyceridaemia: an update
• Hypertriglyceridemia: rationale, design and implementation of the Australian Hypertriglyceridemia Registry
• Identification and Characterization of Two Novel Compounds: Heterozygous Variants of <em>Lipoprotein Lipase</em> in Two Pedigrees With Type I Hyperlipoproteinemia
• Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an "FCS score"
• In vitro assessment of the pathogenicity of the LDLR c.2160delC variant in familial hypercholesterolemia
• LDLR gene's promoter region hypermethylation in patients with familial hypercholesterolemia
• Lipaemia retinalis in familial chylomicronaemia syndrome
• Long-term clinical outcomes and management of hypertriglyceridemia in children with Apo-CII deficiency
• Long-term effects of volanesorsen on triglycerides and pancreatitis in patients with familial chylomicronaemia syndrome (FCS) in the UK Early Access to Medicines Scheme (EAMS)
• Management of a pregnant patient with chylomicronemia from a novel mutation in GPIHBP1: a case report
• Metabolic systems approaches update molecular insights of clinical phenotypes and cardiovascular risk in patients with homozygous familial hypercholesterolemia
• Molecular analysis of three known and one novel LPL variants in patients with type I hyperlipoproteinemia
• Molecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society
• Monogenic hypertriglyceridemia and recurrent pancreatitis in a homozygous carrier of a rare APOA5 mutation: a case report
• Multiple Xanthoma Tuberosum in a Case of Familial Homozygous Hypercholesterolemia
• Non-alcoholic fatty liver disease in patients with chylomicronemia syndromes
• Pancreatitis polygenic risk score is associated with acute pancreatitis in multifactorial chylomicronemia syndrome
• Pancreatitis risk in genetic subtypes of multifactorial chylomicronemia syndrome
• Pharmacological treatment options for severe hypertriglyceridemia and familial chylomicronemia syndrome
• Plaque burden is associated with minimal intimal coverage following drug-eluting stent implantation in an adult familial hypercholesterolemia swine model
• Plasma exchange therapy for familial chylomicronemia syndrome in infant: A case report
• Population screening shows risk of inherited cancer and familial hypercholesterolemia in Oregon
• Post-prandial analysis of fluctuations in the platelet count and platelet function in patients with the familial chylomicronemia syndrome
• Practical definitions of severe versus familial hypercholesterolaemia and hypertriglyceridaemia for adult clinical practice
• Prevalence of familial chylomicronemia syndrome in a quaternary care center
• Prevalence of FH-Causing Variants and Impact on LDL-C Concentration in European, South Asian, and African Ancestry Groups of the UK Biobank-Brief Report
• PROMIS® and Neuro-QoL^TM measures are valid measures of health-related quality of life among patients with familial chylomicronemia syndrome
• Prophylactic therapeutic plasma exchange in pregnant woman with Familial Chylomicronemia Syndrome - A case report
• Qualitative development of the PROMIS Profile v1.0-Familial Chylomicronemia Syndrome (FCS) 28
• Rare Variants in Triglycerides-Related Genes Increase Pancreatitis Risk in Multifactorial Chylomicronemia Syndrome
• Reduced psychological distress in familial chylomicronemia syndrome after patient support group intervention
• Role of lipoprotein lipase activity measurement in the diagnosis of familial chylomicronemia syndrome
• Roundtable discussion: Familial chylomicronemia syndrome: Diagnosis and management
• Roundtable on etiology of familial chylomicronemia syndrome
• Safety and efficacy of therapies for chylomicronemia
• Screening program for familial hyperchylomicronemia syndrome detection: Experience of a university health system
• Severe hypertriglyceridemia as a cause of necrotizing pancreatitis in a pediatric patient with familial hyperchylomicronemia syndrome: A case report
• Spectrum of Mutations and Long-Term Clinical Outcomes in Genetic Chylomicronemia Syndromes
• Subtyping Severe Hypercholesterolemia by Genetic Determinant to Stratify Risk of Coronary Artery Disease
• Symptoms and impacts of familial chylomicronemia syndrome: a qualitative study of the patient experience
• The Association of Thyroid-Stimulating Hormone (TSH) Levels and Lipid Profile in Euthyroid Patients with Familial Hypercholesterolemia
• The burden of familial chylomicronemia syndrome in Canadian patients
• The burden of familial chylomicronemia syndrome: Results from the global IN-FOCUS study
• The effect of volanesorsen treatment on the burden associated with familial chylomicronemia syndrome: the results of the ReFOCUS study
• The longitudinal triglyceride phenotype in heterozygotes with LPL pathogenic variants
• The role of genetic testing in dyslipidaemia
• Trends and hotspots in familial hypercholesterolemia: A bibliometric systematic review from 2002 to 2022
• Update lipidology : Evidence-based treatment of dyslipidemia
• Validation of the familial chylomicronaemia syndrome (FCS) score in an ethnically diverse cohort from UK FCS registry: Implications for diagnosis and differentiation from multifactorial chylomicronaemia syndrome (MCS)
• Variability of longitudinal triglyceride phenotype in patients heterozygous for pathogenic APOA5 variants
• Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome
• Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial
• Volanesorsen in the Treatment of Familial Chylomicronemia Syndrome or Hypertriglyceridaemia: Design, Development and Place in Therapy
• Volanesorsen: First Global Approval
• Yield of Familial Hypercholesterolemia Genetic and Phenotypic Diagnoses After Electronic Health Record and Genomic Data Screening